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Tissue factor pathway inhibitor-2 (Tfpi-2) is an important serine protease inhibitor in the extracellular
matrix (ECM), but its precise physiological signiﬁcance remains unknown. This work is part of a series of
studies intended to investigate functional roles of Tfpi-2 and explore the underlying molecular
mechanisms. First, we cloned and identiﬁed zebraﬁsh Tfpi-2 (zTfpi-2) as an evolutionarily conserved
protein essential for zebraﬁsh development. We also demonstrated that ztfpi-2 is mainly expressed in the
central nervous system (CNS) of zebraﬁsh, and embryonic depletion of ztfpi-2 caused severe CNS defects.
In addition, changes of neural markers, including pax2a, egr2b, huC, ngn1, gfap and olig2, conﬁrmed the
presence of developmental abnormalities in the relevant regions of ztfpi-2 morphants. Using microarray
analysis, we found that members of the Notch pathway, especially her4 and mib, which mediate lateral
inhibition in CNS development, were also downregulated. Intriguingly, both her4 and mib were able to
partially rescue the ztfpi-2morphant phenotype. Furthermore, Morpholino knockdown of ztfpi-2 resulted
in upregulation of neuronal markers while downregulation of glial markers, providing evidence that the
Notch pathway is probably involved in ztfpi-2-mediated CNS development.
& 2013 Elsevier Inc. All rights reserved.Introduction
Human tfpi-2 (htfpi-2), which has been mapped to chromo-
some7q22 (chr7q22) by ﬂuorescence in situ hybridization (Miyagi
et al., 1996a), consists of ﬁve exons and four introns (Kamei et al.,
2001). It is a protease inhibitor with three Kunitz domains (KD)
homologous to tissue factor pathway inhibitor (Tfpi). Tfpi-2 is also
known as placenta protein-5 (PP5) and as matrix-associated serine
protease inhibitor. It belongs to the serine protease inhibitor
superfamily (Rao et al., 1996). Most of the Tfpi-2 triplets derived
from an initial 25 kDa non-glycosylated protein with different
degrees of glycosylation are associated with the ECM (Iino et al.,
1998; Rao et al., 1996). Several organs, including the liver, heart,
kidney, skeletal muscle, pancreas and placenta, express tfpi-2
(Miyagi et al., 1994, 1996b). A wide variety of cell types, such as
epithelial cells, macrophages, T cells, monocytes, syncytiotropho-
blast cells, ﬁbroblasts, endothelial cells and smooth muscle cells,
can synthesize and secrete Tfpi-2 (Crawley et al., 2002; Hube et al.,ll rights reserved.
Hospital, 130 Dongan Road,
632.2003). Tfpi-2 can inhibit plasmin, trypsin, chymotrypsin, cathepsin G,
plasma kallikrein and the VIIa–tissue factor complex but it cannot
inhibit urokinase-type plasminogen activators, tissue-type plasmino-
gen activators or thrombin (Butzow et al., 1988). Because Tfpi-2
inhibits several serine proteases in the ECM, it is thought that it may
play a regulated role in processes of histogenesis, embryonic devel-
opment and wound healing. Previous studies have reported that
Tfpi-2 can inhibit plaque disruption in atherosclerosis (Herman et al.,
2001) and regulate inﬂammation and apoptosis (Peerschke et al.,
2004). Additionally, Tfpi-2 has been shown to inhibit the metastasis
of various tumors, including ﬁbrosarcomas (Chand et al., 2004),
gliomas (Konduri et al., 2003), colorectal cancers (Glockner et al.,
2009) and prostate carcinomas (Ribarska et al., 2010). The cDNA and
amino acid (aa) sequences of bovine tfpi-2 (btfpi-2) and chr4 and of
mouse tfpi-2 (mtfpi-2) and chr6 have also been identiﬁed. Although
the function of tfpi-2 has been investigated in several species,
knockouts of tfpi-2 in animal models have not yet been reported.
Furthermore, the physiological functions of tfpi-2, especially in
embryonic development, remain unknown, which substantially
limits its therapeutic applications. Since the early 1990s, zebraﬁsh
have been widely used in developmental biology as an ideal
vertebrate model system due to their unique advantages for
researching embryo development and gene functions (Kimmel
Y. Zhang et al. / Developmental Biology 381 (2013) 38–49 39et al., 1995). Their optical clarity, external embryogenesis, and fast
development allow for analysis of gene activities during brain
development (Woo and Fraser, 1995) and facilitate our study on
the physiological roles of tfpi-2 and its effects on developmental
processes of the central nervous system.
In zebraﬁsh embryos, Notch signaling via lateral inhibition
mediates the selection of a subset of neural progenitors that will
become early neurons (Itoh et al., 2003). These cells are singled
out from the proneuronal domain in the neural plate, where they
express neurogenin (ngn1), which drives the expression of zebra-
ﬁsh Delta homologs. Then, with the help of E3 ubiquitin ligase
(Mib), these Delta homologs activate Notch, a transmembrane
receptor on neighboring cells, leading to the expression of her4, a
member of the Hairy and Enhancer of Split-Related (Her) basic
helix-loop-helix (b-HLH) repressor gene family, which inhibits the
function of ngn1 and prevents cells from differentiating into
neurons.
Here, zebraﬁsh was used as a model organism, for the ﬁrst
time, to investigate the physiological roles of tfpi-2 and its
potential roles during embryonic development. We deﬁned ztfpi-
2 and analyzed its expression patterns during embryonic devel-
opment. The sequence of ztfpi-2, which we mapped to chr19,
consisted of ﬁve exons and four introns, as in htfpi-2. Bioinfor-
matics analysis revealed that the ztfpi-2 cDNA comprised a
complete open reading frame (ORF) encoding 233 aa residues
with three KDs, similar to the ORF of htfpi-2. However, we also
demonstrated that ztfpi-2 was mainly localized to the zebraﬁsh
CNS. Although injection of ztfpi-2 morpholino (MO) antisense
oligonucleotides was associated with neurogenic phenotypes
observed at 25 hours post fertilization (hpf), co-injection with
mRNA of her4 and mib was found to reduce the rate of these
phenotypes signiﬁcantly. This study provides insight into the
physiological signiﬁcance of Tfpi-2 in vertebrates and clariﬁes
the role of serine proteases during embryonic development.Materials and methods
Zebraﬁsh strains and maintenance
Wild-type (AB strain) zebraﬁsh stocks were obtained from the
International Zebraﬁsh Research Center (University of Oregon, OR,
U.S.). Embryos were obtained from the natural spawning of wild-
type adults. The zebraﬁsh were raised, maintained and staged as
previously described (Kimmel et al., 1995). Transgenic HuC-GFP
and GFAP-GFP zebraﬁsh embryos were provided by Dr. Jinlin Du.
To block pigment formation in the embryos, 0.003% phenyl-
thiourea (PTU) was added to the media at 18 hpf and replenished
every 24 h thereafter.
Rapid ampliﬁcation of cDNA ends (RACE)
We performed a BLAST search in the Trust Sanger Institute
database (http://www.sanger.ac.uk/Projects/D_rerio/) using the
hTfpi-2 aa sequence as the query, and a zebraﬁsh Genscan ID
(ENSDARP00000019243) was identiﬁed. Total RNA from 24 hpf
zebraﬁsh embryos was prepared using a Trizol kit (Invitrogen,
U.S.), and the mRNA was puriﬁed using the Nucleic Acid Puiriﬁca-
tion kit (BD Biosciences Clontech), according to the manufacturer's
instructions. The cDNA cloning of ztfpi-2 was performed by RACE
using the SMART method with amelioration. Brieﬂy, the SMART
cDNA was transcribed using P5SMART and P3SMART primers and
puriﬁed from unincorporated nucleotides and small (o0.1 kb)
cDNA fragments by column chromatography. The whole, puriﬁed
cDNA strands were ampliﬁed using P5SMART and P3 primers, and
the products were then cleaved by KpnI restriction enzymes andcycled using T4 DNA ligase. The cycled PCR products were used as
templates in another set of PCR cycles using the P5RACE outer and
P3RACE outer primers. Then, nested PCR was conducted using
P5RACE inner and P3RACE inner primers, and the products were
cloned into the pGEM-T vector and sequenced. Based on the
results of the RACE analysis, we designed the Pztfpi-2F and
Pztfpi-2R primers to perform RT-PCR, and the products were
cloned into pcDNA3.0. Primer sequences used in this study are
listed in Table S1.
Whole mount in situ hybridization (WISH)
The ztfpi-2 antisense cRNA probe used in the experiment was
taken from bp −25 to +775 (the translational start site ATG was
designated +1). The sense cRNA, which was used as a control
probe, was produced from the same vector as the antisense probe.
Plasmids encoding zebraﬁsh ngn1, olig2, egr2b and pax2a were
provided by Yuebo Gong. All labeled probes were synthesized by
an in vitro transcript reaction according the manufacturer's
instructions. Brieﬂy, DIG-labeled antisense RNA probes were
produced using a DIG-RNA labeling kit (Roche, U.S.) following
the manufacturer's instructions. Hybridization and detection with
an anti-DIG antibody coupled to alkaline phosphatase were
performed with ﬁxed zebraﬁsh embryos injected with 1 mM
Mcon-MO or 0.5 mM SP-MO at 25 hpf. For pax2a, egr2b, ngn1,
and olig2 antisense probes, the NBT/BCIP coloring reactions
proceeded at approximately 20 1C for 2 h, 2 h, 1 h and 1 h,
respectively. The dark blue to purple color visible in each ﬁgure
corresponds to localization of transcript expression.
Quantitative real time PCR (qPCR)
For tissue distribution, we isolated total RNA of the eye, heart,
liver, brain, and ovary; thereafter, qPCR was conducted using SYBR
green (Applied Biosystems). The data were collected using the
ABI7300 system (Applied Biosystems) and analyzed by the
sequence detection software 3.1 (Applied Biosystems).
Histology and electron microscopy
To section the embryos, whole mount in situ hybridized
embryos were ﬁxed in 4% paraformaldehyde (PFA) in PBS over-
night at 4 1C. The embryos were then washed with PBST three
times for 5 min each to remove the ﬁxative. This procedure was
followed by a two-step embedding process: the ﬁrst step involved
a 1.5% agarose in 5% sucrose solution to adjust for embryo
orientation, and the other step used O.C.T. compound (Tissue-
Tek, Sakura) to allow for sectioning.
Western blot analysis
Embryos at 24 hpf were dechorionated and homogenized in
RIPA buffer (Cell Signaling) containing a protease inhibitor cocktail
and phosphatase inhibitor (Roche). Total cellular protein concen-
trations were assessed using a Bio-Rad protein assay kit. Signals
were detected with rabbit polyclonal anti-Tfpi-2 (Immunogen;
1:1000) and mouse monoclonal anti-acetylated tubulin (Sigma;
1:2000) overnight at 4 1C, followed by incubation with the appro-
priate secondary antibody. A ECLTM Western blotting analysis
system (GE Company) was used to detect the bands according to
the protocols.
Morpholino antisense oligonucleotides and mRNA microinjections
Morpholinos (MOs) were obtained from Gene Tools, LLC (U.S.)
and resuspended in nuclease-free water (Eisen and Smith, 2008).
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volume of 1 nl were injected into one- to two-cell stage embryos.
For ztfpi-2, the sequence of the splice-inhibiting MO (SP-MO)
complementary to exon/intron 2 and that of the translation-
blocking MO (ATG-MO) against the start codon were as follows:
5′-GAAAATGAACGTACTTGGTATCCTG-3′ and 5′-GCTCCGAGTAAAT-
CACACGCCATTG-3′, respectively. The sequence of the ﬁve mis-
match control (Mcon-MO) for the SP-MOs, the standard control
(Scon-MO) and p53-MO are listed below: 5′-GAtAATcAACc-
TACTTGcTATCgTG-3′;5′-CCTCTTACCTCAGTTACAATTTATA-3′;5′-GC-
GCCATTGCTTTGCAAGAATTG-3′. The speciﬁcity of the two ztfpi-2
MOs was veriﬁed by BLAST on the Ensemble web site (Wellcome
Trust Sanger Institute, NCBI Project ID: 11776).
Capped and polyadenylated RNA of ztfpi-2, her4 and mib were
synthesized in vitro by transcription with T7 RNA polymerase
using the mMessage mMachine T7 Ultra Kit (Ambion). Both her4
and mib cDNA, obtained from the zebraﬁsh cDNA library at 24 hpf
by RT-PCR, were cloned into PTA2 (Toyobo), and the two con-
structs were linearized by NotI using standard molecular biology
procedures. ztfpi-2 RNA was transcribed from P7TS-ztfpi-2 and
linearized with EcoRI. All injections were performed at least three
separate times. For rescue experiments, RNA and MOs were mixed
and co-injected in a volume of 1 nl into embryos at the 1 cell stage.
RT-PCR and plasmid construction
The RT-PCR was performed using a one-step RT-PCR kit (Qia-
gen, Germany) according to the manufacturer's recommendations
excepting only that the annealing temperature was changed,
depending on the Tm value of the primers. PCR primers (splice
primers) were used to detect targeted exons 1 and 3, skipping
exon 2.
A total of 239 base pair fragments from the 5′ arm sequence of
the ztfpi-2 cDNA were ampliﬁed (239 primers) and cloned to the
MCS of pEGFP-N1, which was doubly cut by XhoI and BamHI to
produce the pEGFP-N1-ztfpi-2 recombinant plasmid. This plasmid
was used to detect the effects of ATG-MO.
Affymetrix array
Shanghai Genetech Ltd. was entrusted with the Affymetrix
array and analysis, which compared the control zebraﬁsh and the
ztfpi-2 morphants to determine the genes involved in the ztfpi-2
downregulation process. Brieﬂy, the ztfpi-2 SP-MO and the Scon-
MO (about 4 ng/cell) were microinjected into zebraﬁsh embryos at
the one-cell stage. When embryos developed to 24 hpf, a total of
10 μg of pooled total RNA from the control and ztfpi-2 down-
regulated embryos was converted to cDNA and labeled with the
GeneChip IVT labeling kit (Affymetrix). Hybridization was per-
formed according to manufacturer's protocol, and the results were
analyzed using the Affymetrix website.
Whole-mount immunohistochemistry
Zebraﬁsh embryos at 25 hpf were ﬁxed with 4% PFA. Neuronal
cells were identiﬁed by immunohistochemistry using with anti–
HuC/HuD mouse monoclonal antibody (1:200, Life Technology,
USA) and 1:500 Alexa red according to standard protocols.
Photography
Stained embryos were examined with Olympus BX61 and
SZX12 microscopes and photographed with a DP 70 digital camera.
Images were processed using Adobe Photoshop software.Statistical analysis
Data analyses were performed using SPSS12.0 for Windows
statistical program. All data were presented as means7SE. Statis-
tical analysis was performed by one-way analysis of variance
(ANOVA). The signiﬁcance level was set at Po0.05.Results
Cloning of ztfpi-2 and sequence analysis
As a ﬁrst step toward the analysis of ztfpi-2, we identiﬁed a
zebraﬁsh Genscan ID (ENSDARP00000019243), which is a counter-
part of htfpi-2, in the Sanger zebraﬁsh genomic sequence project
database. Based on the EST sequence, we obtained a cDNA
fragment of 1077 base pairs (bp), which included the 5′UTR,
3′UTR and full-length ORF, consisting of 702 bp, by means of the
RACE method optimized by SMART technology. The in-frame
initiator codon (ATG) is located at base pairs 76–78 and the
terminator codon (TAG) is located at base pairs 775–777
(Fig. S1).The precursor mRNA sequence of ztfpi-2 has been sub-
mitted to GenBank (DQ395301). Using the ztfpi-2 cDNA sequence
to conduct a BLAST search in the Sanger database, we character-
ized the genomic sequence of the ztfpi-2 gene, which spans
approximately 7790 bp and contains ﬁve exons and four introns.
The putative splice junctions conformed to donor/acceptor con-
sensus sequences (Fig. S2), and the structure of the gene is shown
as a sketch map in Fig. S3A.
Sequence analysis was conducted online using the NCBI blastN
server, the Ensembl blastX server and the ExPASY server. The ztfpi-2
mRNA encoded a protein of 233 aa, and the theoretical molecular
weight of the novel protein was estimated to be 26802.68 Da. zTfpi-
2 was also determined to have a basic charge (pI: 8.80). After
analyzing the aa sequence of zTfpi-2, we found that zTfpi-2 also
contained three tandem KDs, which showed similar scores to those
of their counterparts in hTfpi-2 (Fig. S3B). AA CompIdent, Prosite,
and SignalP software in the ExPASY server and Psort and Motifscan
software in the GenomNet server all revealed that the zTfpi-2
protein contains three KDs and a signal peptide (aa residues 1–
21); aa 30–80, 90–140, and 150–200 were found have been produced
by KD1, 2, and 3, respectively. Comparison of the ztfpi-2 gene
sequence to that of the previously published htfpi-2 cDNA sequence
revealed that exon 1 encodes the amino-terminal region of the
protein, including the putative signal peptide. The three Kunitz-type
domains of tfpi-2 are individually encoded by exons 2, 3 and 4. Exon
5 encodes the carboxy-terminal region of the protein and the entire
3′-ﬂanking region. An N-glycosylation site was found by NetNGlyc
1.0 on the ExPASY server at the 109 N site. The Tfpi-2 sequence of
several organisms was aligned so that their similarities could be
evaluated using CLUSTALW (Fig. 1), and a phylogram was created
(Fig. S3C).
Location of ztfpi-2 expression
To obtain more information on the temporal and spatial
expression patterns of ztfpi-2, we performed RT-PCR and WISH
analysis of wild-type embryos at different developmental stages.
Using RT-PCR, ztfpi-2 transcript was detected from the 1-cell stage
through adulthood (Fig. 2A). WISH conﬁrmed the presence of
ztfpi-2 mRNA in the following stages (Fig. 2B): the 2-cell stage
(0.75 hpf), the 1k-cell stage (3 hpf), the shield stage (6 hpf), and
the 6-somite stage (12 hpf). At 24 hpf, ztfpi-2 gene expression was
restricted to the brain. From then, there were no signiﬁcant
alterations in the expression patterns of ztfpi-2 compared to the
24 hpf embryos. While the negative control using the sense cRNA
Fig. 2. Expression of ztfpi-2 during zebraﬁsh embryogenesis. (A) RT-PCR detection
of maternal and zygotic ztfpi-2 transcript from 1-cell stage to adult zebraﬁsh.
(B) Pattern of expression of ztfpi-2 as shown using WISH. Stages of development are
indicated in the bottom right corner. The expression of ztfpi-2 is indicated by
arrows.Fig. 1. Alignment of the Tfpi-2 sequences of different species. Gaps, which were
inserted to optimize the alignments, are indicated by dots. Amino acid residues
identical to the human Tfpi-2 sequence are marked in dark grey.
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qPCR to analyze the tissue distribution of this gene in adult ﬁsh.
The qPCR results showed different levels of ztfpi-2 expression
in different tissues, with the highest distribution in the brain
(Fig. S4). In this way, the expression patterns of ztfpi-2 in the adult
ﬁsh, which were most abundant in the brain, were consistent with
those of the embryonic ﬁsh at 24 hpf. From these results, we
deduced that ztfpi-2 might play an important role in the brain
development and function of the nervous system.
Speciﬁcity of MOs and effects on ztfpi-2 expression
To investigate the role of ztfpi-2 in early development, we
performed MO-based knockdown studies of ztfpi-2. A BLAST search
of the zebraﬁsh genome database (Zv9) veriﬁed that the target sites
for the two MOs were speciﬁc to ztfpi-2. The effect of the SP-MO,
which was complementary to the exon/intron 2 junction, was
conﬁrmed by sequence analysis of ztfpi-2mRNA (Fig. S5). We injected
varying doses of SP-MO into fertilized eggs at the one-cell stage, left
them to develop until 24 hpf, and used RT-PCR to determine which
splice variants of ztfpi-2 mRNA were present. As shown in Fig. 3A,
0.5 mM of the SP-MO produced an obvious reduction in the amount of
normally splicedmRNA. At 1 mM, this reductionwasmore remarkablethan that produced by 1mM Scon-MO or 1mM Mcon-MO, resulting
in more severe phenotypes (Table 1; Fig. S6). The predominant mRNA
was a splice variant encoding an altered splice protein. We sequenced
this splice variant and found an aberrant splice product, a ∼41 bp
deletion, compared to the mRNA ampliﬁed from the control (Fig. 3B).
This deletion resulted from the aberrant use of a cryptic splice donor
site located 39 bp upstream of the correct exon 2 splice donor. Splicing
at this cryptic splice donor site shifted the reading frame of ztfpi-2
mRNA such that only 71 of the 233 aa were encoded. Concomitantly,
the frame-shift mutation induced a stop codon at the 102 site (Fig. S5;
Fig. 3B). As a result, this severely truncated form from ztfpi-2 was
predicted to be non-functional, especially because there was no
formation of any integrated Kunitz-type domain, which is critical to
the biological functions of tfpi-2.
The ATG-MO complementary to the 25 nucleotides of the ztfpi-
2 mRNA (including the ATG) was synthesized to block ztfpi-2
translation. A series of dosages of ATG-MO was tested and the
same phenotype with SP-MO was observed (Fig. S6). To minimize
the off-target effects of the MOs, 0.3 mM ATG-MO and 0.5 mM SP-
MO were co-injected, which resulted in synergism and more
severe phenotypes (Table 1). We examined the effects of ATG-
MO by artiﬁcially expressing the pEGFP-N1-ztfpi-2 recombinant
plasmid alone or with the ATG-MO in sibling embryos. In the
absence of the ATG-MO, the mosaic expression of zTfpi-2-EGFP
Fig. 3. Efﬁciency of ztfpi-2 knockdown by MOs. (A) The SP-MO altered splicing in zebraﬁsh. The results showed a MO concentration-dependent decrease of ztfpi-2 RNA levels,
which indicated that the SP-MO successfully downregulated the expression of ztfpi-2 at 24 hpf. (B) Sequence comparison of ztfpi-2 revealed that 41 bp of exon 2 was lost due
to a frameshift mutation after bp 71, leading to a stop codon at bp 102. (C) ATG-MO knockdown of the zTfpi-2-EGFP fusion protein at 8 hpf. Green ﬂuorescence was
detectable in a mosaic pattern throughout embryos injected with the zTfpi-2-EGFP plasmid at 38 pg, while GFP expression was absent in nearly all embryos co-injected with
0.6 mM ATG-MO and wild-type embryos without injection. (D) Western blot analysis of zTfpi-2 knockdown efﬁciency. Embryos injected with 0.5 mM SP-MO or 0.6 mM ATG-
MO were harvested at 24 hpf. Tubulin was used as the loading control. Gray scale analysis showed that zTfpi-2 was reduced to 48% of former levels by SP-MO and to 53% by
ATG-MO.
Table 1
Phenotypes of the ztfpi-2 knockdown morphants.
MOs (per nl) Total number (n) Normal (n) Mild (n) Severe (n)
Scon (1 mM) 75 84% (63) 9% (7) 7% (5)
TB (0.3 mM) 78 44% (34) 32% (25) 24% (19)
TB (0.6 mM) 88 30% (26) 25% (22) 45% (40)
Mcon (1 mM) 125 80% (100) 11% (14) 9% (11)
KD (0.5 mM) 168 21% (35) 46% (77) 33% (56)
KD (1 mM) 92 17% (16) 31% (28) 52% (48)
KD+TB (0.5 mM
+0.3 mM)
71 0% (0) 14% (10) 86% (61)
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ATG-MO to the pEGFP-N1-ztfpi-2 recombinant plasmid injection
mixture, this GFP expression was abolished. Although it is difﬁcult
to quantify these observations, the effect was clear. Meanwhile,
the effects of MOs on ztfpi-2 protein levels were veriﬁed by anti-
Tfpi-2 staining. In contrast to the control, both SP-MO and ATG-
MO caused a marked loss of zTfpi-2, as indicated by Western blot
analysis (Fig. 3D).
Effects of ztfpi-2 knockdown on neurogenic defects
At a gross anatomical level, embryos injected with the SP-MO,
displayed reproducible abnormalities in the midbrain and hind-
brain, especially at the midbrain-hindbrain boundary (MHB), with
subsequent pigment deﬁciencies and reduced spontaneous move-
ment compared to embryos injected with the Mcon-MO at 25 hpf
(Fig. 4A). The size and lumen of the third and fourth ventricles was
also markedly reduced. At 36 hpf, severe developmental defects,
including large yolk-sacs, pericardial sac edema and reduced bodylength were observed (data not shown). For further investigation,
we classiﬁed the morphants based on their neurogenic pheno-
types at 25 hpf: (1) wild-type without abnormality; (2) mild
phenotype, including narrowed-ventricles and pigment deﬁcien-
cies; and (3) severe phenotype, including lack of the MHB, serious
pigment deﬁciencies and less frequent spontaneous movement
(Fig. S6). Statistic results of zTfpi-2 morphants were shown in
Table 1.
Next, we tested whether the neuronal phenotype observed was
non-speciﬁc effects of morpholinos dependent of the activation of
P53 and consequent P53-induced apoptosis (Eisen and Smith,
2008). SP-MO was co-injected with p53-MO and no obvious
difference was observed between ztfpi-2 morphants with and
without p53-MO (Fig. 4A). Then cell death was assessed in the
ztfpi-2morphants at different stages by TUNEL assay. Analysis of z-
stack images revealed that there were no more TUNEL-positive
cells in embryos injected with SP-MO or ATG-MO than control at
12 hpf or 24 hpf (Fig. S7). By 36 hpf, the number of positive cells
remained unchanged in the brain. To determine whether the
neurogenic phenotypes were due to speciﬁc or nonspeciﬁc effects
of the SP-MO, we co-injected in vitro transcribed ztfpi-2 mRNA and
assayed for rescue of the defects. This transcribed ztfpi-2 mRNA
corresponded to the wild-type mRNA and was immune to the
SP-MO. We found that 75 pg ztfpi-2mRNA could rescue the defects
in a large fraction of embryos (Fig. 4A and B). Embryos injected
with 75 pg ztfpi-2 mRNA did not show any phenotypic difference
from controls (data not shown). These results conﬁrmed that the
developmental defects of ztfpi-2 morphants were the result of
speciﬁc inhibition of ztfpi-2 function.
We next determined whether the midbrain and retina photo-
receptor cells could be affected by SP-MO. The density of the nerve
ﬁbers at the MHB following treatment with the SP-MO was sparse
Fig. 4. Morphological defects exhibited in ztfpi-2 morphants. (A) SP-MO injected and p53-MO co-injected embryos displayed malformation of the MHB with pigment
deﬁciencies 25 hpf but embryos exposed to Mcon-MO and Scon-MO did not (arrow). These morphological phenotypes were found to be rescued by concomitant injection of
ztfpi-2 mRNA. (B) ztfpi-2-deﬁcient embryos were partially rescued by co-injection of 75 pg ztfpi-2, 155 pg her4, and 85 pg mib mRNA. A total of 100 embryos were used per
group. Representative results of three independent experiments are shown.
Y. Zhang et al. / Developmental Biology 381 (2013) 38–49 43(Fig. S8B). With respect to the retina, we found that the arrange-
ment of photoreceptor cells lost its regularity following ztfpi-2
knockdown (Fig. S8C). These results were revealed by the H&E
stained slides and electron microscopy.
To understand how the patterning of the midbrain and hind-
brain was affected we examined the expression of the region-
speciﬁc marker genes by in situ hybridization, including pax2a for
MHB (Krauss et al., 1992; Picker et al., 2002), egr2b for rhombo-
meres (Kimmel et al., 1995; Oxtoby and Jowett, 1993). WISH
showed that levels of pax2a (78%, n¼35; Fig. 5A), egr2b (83%,
n¼37; Fig. 5B) were lower in the CNS of ztfpi-2-defective embryos
injected with the SP-MO at 25 hpf than in the Mcon-MO-injected
embryos; ztfpi-2 mRNA was able to rescue these defects.These morphological defects exhibited in the ztfpi-2 morphants,
including irregular hindbrain patterning, reduction of melanocytes
and disorganization of the optic vesicle, closely resembled abnorm-
alities characteristic of the loss of the Notch pathway (Bernardos
et al., 2005; Zhang et al., 2007). Additionally, further experiments
demonstrated a relationship between ztfpi-2 and Notch signaling,
which might be functionally important for CNS development.
Effects of ztfpi-2 knockdown on her4 and mib
Using microarray analysis, about 1300 genes were shown to be
upregulated and about 1200 genes were found to be downregulated
when ztfpi-2 was knocked down. We found that approximately 600
Fig. 5. ztfpi-2 regulated the development of the midbrain and hindbrain. All views are lateral. Expression of pax2a in the MHB (A) egr2b in rhombomere 5 (B) at 25 hpf.
Embryos injected with 0.5 mM SP-MO displayed weaker expression of pax2a (arrow) and egr2b (asterisk) than those exposed to 0.5 mM Mcon-MO, while wild-type ztfpi-2
RNA was able to rescue their expression in the same region. Also, her4 and mib were able to partially rescue the ztfpi-2 defects in the midbrain and hindbrain. Scale bar:
50 μm.
Y. Zhang et al. / Developmental Biology 381 (2013) 38–4944of the genes were up- or downregulated by 2-fold or more (Tables S2
and S3). These genes encoded structural proteins, enzymes, signal
transducers, hemostasis factors, and transcription factors. From the
differentially expressed genes in the ztfpi-2 morphants, we selected
those whose level of expression had changed more than 4-fold forfurther analysis (Table 2). These genes included receptors of the
G-protein family (mc1r), members of the Notch signaling pathway
(mib), members of matrix metalloproteinase family (mmp-9 and
mmp-13), and cell-cycle-related factors (p53). Notch1a, Mib and
Her4 play pivotal roles in the Notch signaling pathway. Interestingly,
Y. Zhang et al. / Developmental Biology 381 (2013) 38–49 45all of them were downregulated and the result was veriﬁed by qPCR
(Fig. 6A). To determine when these changes are ﬁrst seen, we
detected expression of her4 and mib, the two smaller molecular, at
different stages. The results revealed that both her4 and mib were
reduced as early as 3 somites stage (Fig. 6B). Furthermore, WISH also
showed that two of them were downregulated (Fig. 6C and D). And
ztfpi-2 mRNA could rescue her4 expression (41%, n¼105 and 53%,Fig. 6. Three members of the Notch pathway were downregulated. (A) The graph shows
knocked down at 24 hpf. Asterisks indicate a signiﬁcant difference from the Mcon-MO g
were reduced as early as 3 somites stage. ((C), (D)) WISH indicated that her4 and mib w
3 somites stage and 25 hpf.
Table 2
Genes decreased greater than 4-fold following downregulation of ztfpi-2.
GenBank accession no. Gene symbol Signal log ratio
Metabolism
NM_173286 Mib −2.1
NM_180970 mc1r −3.1
NM_001006066 zgc:101717 −5.8
Cell cycle, biosynthesis, division
NM_131663 Star −4.5
NM_001004575 Pfkm −2.1
NM_153674 vangl2 −4.3
NM_201449 cdc27 −2.0
XM_688139 jmjd2al −3.6
NM_001020565 zgc:110064 −2.1
NM_131802 cp −2.5
Response to stimulus
XM_688139 jmjd2al −3.6
Development
NM_153674 vangl2 −4.3n¼82) andmib expression (40%, n¼110 and 55%, n¼76) at 3 somites
stage and 25 hpf.
We next conducted rescue experiments using wild-type RNAs of
her4 andmib. Capped and polyadenylated RNAs of her4 andmibwere
synthesized in vitro to upregulate their expression in embryos co-
injected with the SP-MO. Upon co-injection with 0.5 mM SP-MO,
both 155 pg of her4 mRNA and 85 pg of mib mRNA were able to
partially rescue the ztfpi-2 brain defects (Figs. 4B and 5).Effects of ztfpi-2 downregulation on neuron and glial speciﬁcation
Previous studies have shown that Notch signaling not only
represses the expression of neural genes during neurogenesis but
also promotes the differentiation of glial cells. To demonstrate the
connection to Notch signaling, we assessed the levels of the
neuron marker huC and the proneural marker ngn1 in ztfpi-2
depleted embryos (Chung et al., 2011; Kim et al., 1996). A
comparison of relative gene expression in the embryos injected
with the Mcon-MO and the SP-MO revealed that both huC and
ngn1 were upregulated at 25 hpf (Fig. 7A). WISH and qPCR showed
that, there were more huC-positive cells in morphant embryos
than in wild-type specimens as early as the 3 somites stage
(Fig. 7B; Fig. S9A). Consistent with this, the HuC-GFP transgenic
zebraﬁsh, in which the huC promoter drove GFP expression to
identify differentiating neurons (Park et al., 2000), showed HuC-
positive cells increased in ztfpi-2 morphant embryos at 25 hpf
(61%, n¼43; Fig. 7C), after the injection with the SP-MO. Usingthe results of qPCR analyses of her4, mib and Notch1αmRNA levels when ztfpi-2 was
roup (Student's t test, Po0.05). (B) Results of qPCR showed that both her4 and mib
ere downregulated while ztfpi-2 mRNA could partially recover their expression at
Fig. 7. ztfpi-2 morphants exhibited upregulation of huC and ngn1. (A) qPCR analysis showed huC and ngn1 levels have been increased in embryos injected with SP-MO at
25 hpf. nPo0.05. (B) WISH showed, at the 3-somite stage, injected embryos had a higher density of neurons in the neural plate than controls. (C) There were more HuC-
positive cells in the SP-MO injected HuC-GFP embryos. A z-stack of ﬂuorescence images was acquired by confocal microscopy at 25 hpf. Scale bar: 100 μm. (D) Dorsal views of
Mcon-MO and SP-MO injected embryos showing ngn1 expression at 3 somites stage. The changes could be restored by co-injection of SP-MO with ztfpi-2 mRNA.
Y. Zhang et al. / Developmental Biology 381 (2013) 38–4946HuC-GFP transgenic zebraﬁsh, specimens overexpressing mib and
her4 were found to have fewer neurons than controls but none of
these effects was altered by co-injection with p53-MO (Fig. S9B).
The data indicated that many cells have been inhibited to become
early neurons, in agreement with previous observation (Itoh et al.,
2003; Yeo et al., 2007). Moreover, whole-mount immunostaining
of HuC/HuD indicated that knockdown of zTfpi-2 increased the
neuronal cells, whereas ztfpi-2 mRNA rescued the defects
(Fig. S10). The results are consistent with those of previous studies
in Drosophila (Itoh et al., 2003). The number of ngn1-positive cells
in SP-MO injected embryos was also higher than in control
at 3 somites stage (60%, n¼31; Fig. 7D). Co-injection with
ztfpi-2 mRNA attenuated the effect of SP-MO indicating that the
neural defects were the result of speciﬁc inhibition of ztfpi-2
function.
Subsequently, we analyzed the effect of ztfpi-2 in glial cells. Real-
time PCR analysis showed lower levels of the glial markers, gfap andolig2, in the SP-MO injected embryos than in the control embryos
(Fig. 8A) (Chen et al., 2010). Corroborating qPCR ﬁndings, the number
of GFAP-positive cells was clearly decreased in GFAP-GFP transgenic
zebraﬁsh embryos injected with SP-MO at 3dpf (70%, n¼68; Fig. 8B).
WISH showed reduction of olig2 in ztfpi-2 knockdown embryos at
25 hpf (66%, n¼28; Fig. 8C); ztfpi-2mRNAwas able to partially rescue
these defects. These data indicated that the speciﬁcation of neurons
and glia was disrupted when ztfpi-2 was downregulated.Discussion
Evolutionary conservatism of Tfpi-2 between zebraﬁsh and mammals
It is thought that Tfpi-2 plays a crucial role in cell migration and
embryonic development (Werb et al., 1999), However, its physio-
logical signiﬁcance remains unknown. This is the ﬁrst paper to
Fig. 8. ztfpi-2 knockdown embryos showed fewer glial cells than controls. (A) SP-
MO injection signiﬁcantly downregulated the expression of the glial markers, gfap
and olig2, and this effect was rescued by co-injection with ztfpi-2 mRNA. *Po0.05.
(B) Dorsal views. The level of gfapwas signiﬁcantly decreased in GFAP-GFP embryos
injected with SP-MO at 72 hpf and GFP was visualized under confocal microscopy.
Scale bar: 100 μm. (C) WISH conﬁrmed the reduction of olig2 in ztfpi-2morphant at
25 hpf.
Y. Zhang et al. / Developmental Biology 381 (2013) 38–49 47identify that the cloned cDNA sequence was the zebraﬁsh counter-
part of tfpi-2. We reported the cloning of the entire cDNA of ztfpi-2
and its pattern of expression during embryogenesis. The length of
zTfpi-2 (233 aa) is similar to that of hTfpi-2 (235 aa), showing
strong homology to hTfpi-2. In human, rat and bovine, Tfpi-2
inhibits a variety of serine proteinases involved processes includ-
ing coagulation and ﬁbrinolysis through its KD1 (Kamei et al.,
1999; Miyagi et al., 1996b). Furthermore, our recent studies have
shown that KD1 of hTfpi-2 harbors most of hTfpi-2′s inhibitory
activities towards plasmin, trypsin and the TF/VII complex (Kong
et al., 2004). We found KD1 to be key to the signiﬁcance of zTfpi-2.
KD1 contains a putative P1 residue for the substrate recognition
sites of serine proteinases. The P1 site mimics an important part of
the substrate structure and associates with the proteinase speci-
ﬁcity crevice. The putative P1 residue of humans, rats, and bovines,
Tfpi-2 KD1, is either arginine or lysine (both of which are basic
amino acids). The corresponding residues of mTfpi-2 and zTfpi-2
are glutamine and asparagine, respectively. For this reason, zTfpi-2
might lose most of its inhibitory activity relative to humans due to
an arginine to asparagine substitution, as in mTfpi-2 (Kamei et al.,
1999).Complexity of neurogenic phenotypes resulting from knockdown of
ztfpi-2
We performed MO experiments using the standard control and
mismatch control recommended by Eisen and Smith (2008). Both
the translation-blocker, ATG-MO, and the splice-inhibitor, SP-MO,
were designed speciﬁcally against the ztfpi-2 gene, and their
effects were veriﬁed. However, the phenotypes observed in the
ztfpi-2 morphants were complex, and our expectations were
confounded because most studies using MOs have reported gen-
erally healthy embryos with few side-effects other than the
speciﬁc phenotypes caused by the knockdown of the targeted
genes. Severe developmental defects were observed after 25 hpf,
even at low concentrations of SP-MO. These phenotypes have
mostly been deﬁned as common nonspeciﬁc or toxic effects of
MOs (Ekker and Larson, 2001; Wright et al., 2004). In this study,
we hypothesized that these phenotypes might be secondary or
complicated phenotypes because they appeared relatively late, in
embryos older than 25 hpf, while the primary defects were
detected earlier. Once one gene with a critical role in early
development is knocked down, a whole series of abnormalities
are displayed, which provides support for our hypothesis.
Involvement of the Notch signaling pathway in the function of ztfpi-2
The expression pattern of ztfpi-2 suggested that it played an
important role in the development of the zebraﬁsh CNS. In
zebraﬁsh adults, ztfpi-2 showed the greatest levels of expression
in the brain. The most obvious morphant phenotypes were also
discovered in the CNS, which corresponded to the expression
pattern of ztfpi-2. Previous studies have shown that Notch activa-
tion regulates the boundary formation within the brain (Cheng
et al., 2004; Louvi and Artavanis-Tsakonas, 2006). These data are
consistent with our ﬁndings that ztfpi-2 knockdown embryos had
severe defects in the CNS. Using WISH and immunoﬂuorescence,
we found that ztfpi-2 was expressed among the CNS nerve ﬁbers.
The present study provided evidence that the downregulation of
ztfpi-2 might prevent differentiation of glia by a mechanism
dependent on inactivation of Notch–Delta signaling, which plays
an instructive role in gliogenesis (Bernardos et al., 2005). Because
oligodendrocytes are pivotal to the myelination of the CNS, it is
possible that the number and shape of CNS ﬁbers will change if
oligodendrocyte differentiation is inhibited.
Studies have shown that Notch signaling mediates a wide range
of essential cell-cell interactions (Artavanis-Tsakonas et al., 1999;
Artavanis-Tsakonas and Simpson, 1991; Itoh et al., 2003). It is best
known for its role in selecting cells to become neuroblasts or
sensory organ precursors. This takes place through lateral inhibi-
tion, in which cells that adopt a neural fate inhibit their neighbors
from doing similarly. As one of the Notch signaling targets, her4 is
a b-HLH transcriptional repressor gene. It acts downstream of
Notch to inhibit neurogenesis. Mib is required for the cellular
localization and activity of Delta, which is essential to the efﬁcient
activation of Notch. Once her4 and/or mib are downregulated, the
Notch pathway loses some of its functions. Here, we showed that
her4 andmib have been downregulated in ztfpi-2morphants. More
importantly, both her4 andmibwere able to partially rescue ztfpi-2
defects in the midbrain and hindbrain. In addition, embryonic
depletion of ztfpi-2 caused upregulation of huC and ngn1 while
downregulation of gfap and olig2, which strongly resembles the
results of inactivation of Notch signaling (Kang et al., 2013; Park
and Appel, 2003). This suggested that ztfpi-2 regulates the devel-
opment of the CNS, likely through a Notch-dependent signaling
pathway.
Certain serine protease inhibitors are related to Notch signal-
ing. PEDF/SERPINF1, which differs from Tfpi-2 in that it does not
Y. Zhang et al. / Developmental Biology 381 (2013) 38–4948contain a Kunitz-type domain, is known to potentiate Notch
activity (Andreu-Agullo et al., 2009). Because it is associated with
the ECM, Tfpi-2 can modulate the Notch pathway by inhibiting
related proteinases, especially extracellular elements. Previous
studies have also shown that Tfpi-2 can be translocated to the
nucleus (Kempaiah et al., 2009). There, it can serve as a trans-
acting factor or even directly as a transcriptional factor, regulating
the expression of members of Notch pathway, including mib, her4,
and Notch receptor. An additional possibility that we cannot as yet
exclude is that the increase in protease activity after zTfpi-2
knockdown might lead to degradation of the ECM proteins that
cause disaggregation of cells and interrupt cell-to-cell contacts.
This might eventually decrease Notch activity and produce a
subsequent neurogenic phenotype, because Notch signaling occurs
after contact between two adjacent cells. For this reason, future
studies are necessary to determine the potential candidates
involved in this pathway that act alongside Tfpi-2. Studies invol-
ving recombinant protein and potential interaction partners may
increase our understanding of the roles of Tfpi-2 in the regulation
of embryonic development.Acknowledgments
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